- Investment sought:
- Equity offered:
We are humanising diabetes technology for better health outcomes and quality of life.
An estimated 92% of nearly 40 million people with insulin-treated diabetes do not achieve recommended medical targets. They’re 2-3 times more likely to have anxiety and depression. Why? The science of diabetes is incomplete, so people fill the gaps with their own trial and error and diabetes technology.
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones to help people decide how much insulin to take and when. We are structuring this data to reveal insights into the causes behind fluctuations in blood glucose and expand diabetes science.
In the past 2 years, 100+ people who take insulin have been guiding our R&D. 76% of Quin users feel better about living with diabetes and 35% have improved their HbA1c – healthcare’s target measure. We now want to launch Quin and help more people achieve the target with a better quality of life.